Whole blood angiopoietin-1 and -2 levels discriminate cerebral and severe (non-cerebral) malaria from uncomplicated malaria.
about
Angiopoietin-1 is essential in mouse vasculature during development and in response to injury.Fighting the Monster: Applying the Host Damage Framework to Human Central Nervous System InfectionsVascular dysfunction as a target for adjuvant therapy in cerebral malariaExperimental cerebral malaria pathogenesis--hemodynamics at the blood brain barrierNeuroimmunological blood brain barrier opening in experimental cerebral malariaPharmacologic inhibition of CXCL10 in combination with anti-malarial therapy eliminates mortality associated with murine model of cerebral malariaCombinations of host biomarkers predict mortality among Ugandan children with severe malaria: a retrospective case-control studyEndothelium-based biomarkers are associated with cerebral malaria in Malawian children: a retrospective case-control studyImaging Plasmodium immunobiology in the liver, brain, and lung.Dysregulation of angiopoietins is associated with placental malaria and low birth weight.Molecular correlates of experimental cerebral malaria detectable in whole bloodImbalance of angiopoietin-1 and angiopoetin-2 in severe dengue and relationship with thrombocytopenia, endothelial activation, and vascular stabilityAngiopoietin-2 and angiopoietin-2/angiopoietin-1 ratio as indicators of potential severity of Plasmodium vivax malaria in patients with thrombocytopenia.A novel role for von Willebrand factor in the pathogenesis of experimental cerebral malariaSystemic and Cerebral Vascular Endothelial Growth Factor Levels Increase in Murine Cerebral Malaria along with Increased Calpain and Caspase Activity and Can be Reduced by Erythropoietin Treatment.The role of angiogenic factors in predicting clinical outcome in severe bacterial infection in Malawian children.New inflammation-related biomarkers during malaria infection.Severe childhood malaria syndromes defined by plasma proteome profiles.Identification of protein markers in patients infected with Plasmodium knowlesi, Plasmodium falciparum and Plasmodium vivax.Platelet activation determines angiopoietin-1 and VEGF levels in malaria: implications for their use as biomarkersInhaled nitric oxide for the adjunctive therapy of severe malaria: protocol for a randomized controlled trial.Angiopoietin-2 levels are associated with retinopathy and predict mortality in Malawian children with cerebral malaria: a retrospective case-control study*Plasma levels of angiopoietin-1 and -2 predict cerebral malaria outcome in Central India.Inhaled Nitric Oxide as an Adjunctive Treatment for Cerebral Malaria in Children: A Phase II Randomized Open-Label Clinical Trial.Pathogenesis of cerebral malaria: new diagnostic tools, biomarkers, and therapeutic approaches.Inhaled nitric oxide as adjunctive therapy for severe malaria: a randomized controlled trialA common TLR1 polymorphism is associated with higher parasitaemia in a Southeast Asian population with Plasmodium falciparum malaria.Study of C reactive protein as a prognostic marker in malaria from Eastern India.Endothelial activation, haemostasis and thrombosis biomarkers in Ugandan children with severe malaria participating in a clinical trial.A clinicopathological correlation of the expression of the angiopoietin-Tie-2 receptor pathway in the brain of adults with Plasmodium falciparum malaria.Evidence of Endothelial Activation in Asymptomatic Plasmodium falciparum Parasitemia and Effect of Blood Group on Levels of von Willebrand Factor in Malaria.Host Biomarkers Are Associated With Response to Therapy and Long-Term Mortality in Pediatric Severe Malaria.Angiotensin receptors and β-catenin regulate brain endothelial integrity in malaria.Systematic review of the role of angiopoietin-1 and angiopoietin-2 in Plasmodium species infections: biomarkers or therapeutic targets?Neuregulin-1 attenuates mortality associated with experimental cerebral malaria.Host biomarkers distinguish dengue from leptospirosis in Colombia: a case-control study.Biomarkers of endothelial activation/dysfunction in infectious diseases.Contrasting pediatric and adult cerebral malaria: the role of the endothelial barrier.Potential biomarkers and their applications for rapid and reliable detection of malaria.Protective or pathogenic effects of vascular endothelial growth factor (VEGF) as potential biomarker in cerebral malaria.
P2860
Q24629743-FDCAFE6B-112D-49BA-8253-D001B6C26DBCQ26774211-DA6583EB-6269-41F9-99B3-B9CE7C3E0D9BQ27025436-3C11EAC9-FB2A-4E4A-A579-10B4DBCB70F0Q27322655-FABE1C77-266E-4848-B23A-1B99800A591DQ27341951-2F1744D9-38CD-49EF-89E3-4A16E39A1B5DQ28486022-43F875B3-8AA9-4DA2-84F1-8ED0C665194BQ28742367-ABB554A9-9D9A-463C-A229-18BD6D69D468Q28743878-137B1479-1A3F-44A7-8766-7702BE414F01Q30561036-CB38BE10-2C48-4D07-A735-2C9177D81C31Q30979156-8EB114CD-8856-46D6-A8B5-08EECEEFF4A3Q33393243-EEED1E7D-8A39-411D-8802-7907E83700BBQ33403135-0CF247F9-0702-4C71-A8CD-971A3F43C8E9Q33417944-85125ED9-30F7-4239-B954-7FE4114E3B35Q33427139-C8815E9A-531E-4CFB-81CB-8E38D0D37AB3Q33775828-5CE54003-76B8-4475-A5EE-EBF91F6E669FQ34026872-C9CE3211-568E-439D-A8B8-D12F2FC98408Q34058614-9EEC6251-C384-48B5-8303-767DC1975E94Q34506428-CF9E8E64-B107-45EB-B0AB-32B048CB97F4Q34685175-2DF7F552-FB32-427C-9B6F-EE3D6D7C7FC8Q34765904-04D7A2B8-6702-4A04-AC25-2D302FBEEBB3Q35150645-2AEF96AC-CFF6-4921-B6BD-0C3DD368CA3CQ35771468-A8AD0150-BCBE-4CFE-911B-05DB3CB9648EQ35777475-C78B20A1-6B7C-4B91-8932-944639247C88Q35972858-05E23537-0360-4B00-896D-9FE70320991CQ36209383-63B8CA76-E11B-447E-884B-D8AAE220387BQ36223174-D21F915B-AAF7-4C0E-9A63-44F759BC6DF0Q36439212-0BA6114A-8CD4-4A51-A40F-61EBC159D560Q36529469-05138ED3-B31B-4525-8B0C-19B57BAD923AQ36530522-2BD2C224-43A8-4967-A98B-F19A9F9ADB8AQ36604263-1D44B316-3A5A-4F88-841A-482999C53624Q36851146-D640AF32-A0EB-499D-883D-DB9C0E681444Q37305512-5BAF2E82-832B-4510-AF0E-C3EC69F2772DQ37395730-60A205EF-E426-430A-B799-703EF9335899Q37466271-BA8BC601-978D-44F4-9478-6FD234A301DCQ37532357-9049A165-2093-4CB5-81D8-85F60BD46299Q37539959-66FD483A-71EE-43BC-925C-F3B66812DC77Q37713182-11FC0BF5-3B8E-44FC-BED5-C973F51799B8Q37713193-BFA691BC-0F63-418B-B866-67C9F1D64631Q37718844-CC50BAFB-C3B2-4B48-8C64-C198007B8B7AQ37734218-04731A7D-73A4-4E19-B7EB-26DBB378512B
P2860
Whole blood angiopoietin-1 and -2 levels discriminate cerebral and severe (non-cerebral) malaria from uncomplicated malaria.
description
2009 nî lūn-bûn
@nan
2009 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
Whole blood angiopoietin-1 and ...... ia from uncomplicated malaria.
@ast
Whole blood angiopoietin-1 and ...... ia from uncomplicated malaria.
@en
type
label
Whole blood angiopoietin-1 and ...... ia from uncomplicated malaria.
@ast
Whole blood angiopoietin-1 and ...... ia from uncomplicated malaria.
@en
prefLabel
Whole blood angiopoietin-1 and ...... ia from uncomplicated malaria.
@ast
Whole blood angiopoietin-1 and ...... ia from uncomplicated malaria.
@en
P2093
P2860
P356
P1433
P1476
Whole blood angiopoietin-1 and ...... ia from uncomplicated malaria.
@en
P2093
Andrea L Conroy
Erin I Lafferty
Fiona E Lovegrove
Noppadon Tangpukdee
W Conrad Liles
P2860
P2888
P356
10.1186/1475-2875-8-295
P577
2009-12-15T00:00:00Z
P5875
P6179
1048704926